- Ownership
-
Artivion, Inc. Insider Trading
* In original currency USD
Loading Data
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price | Total Amount |
|---|---|---|---|---|---|---|---|---|
| Tuesday, June 17th, 2025 | Stanton Marshall S. | officer: SVP, Clinical & MD Affair | 65,436 | S-Sale | D | 13,764 | 29.50 USD | 406,038 USD |
| Tuesday, June 17th, 2025 | Stanton Marshall S. | officer: SVP, Clinical & MD Affair | 64,200 | S-Sale | D | 1,236 | 29.50 USD | 36,462 USD |
| Friday, June 13th, 2025 | Stanton Marshall S. | officer: SVP, Clinical & MD Affair | 96,585 | S-Sale | D | 8,747 | 28.46 USD | 248,953 USD |
| Friday, June 13th, 2025 | Stanton Marshall S. | officer: SVP, Clinical & MD Affair | 95,332 | S-Sale | D | 1,253 | 28.47 USD | 35,669 USD |
| Friday, June 13th, 2025 | Stanton Marshall S. | officer: SVP, Clinical & MD Affair | 81,026 | S-Sale | D | 14,306 | 28.42 USD | 406,601 USD |
| Friday, June 13th, 2025 | Stanton Marshall S. | officer: SVP, Clinical & MD Affair | 79,200 | S-Sale | D | 1,826 | 28.43 USD | 51,909 USD |
| Tuesday, May 27th, 2025 | Holloway Jean F | officer: SVP, General Counsel | 178,510 | S-Sale | D | 8,748 | 29.00 USD | 253,692 USD |
| Friday, May 23rd, 2025 | SEMEDO ANTHONY B. | director | 39,384 | S-Sale | D | 2,600 | 28.47 USD | 74,027 USD |
| Thursday, May 22nd, 2025 | SEMEDO ANTHONY B. | director | 41,984 | A-Award | A | 6,325 | 0.00 USD | 0 USD |
| Thursday, May 22nd, 2025 | Borgstrom Marna P | director | 49,088 | A-Award | A | 6,325 | 0.00 USD | 0 USD |
| Thursday, May 22nd, 2025 | BEVEVINO DANIEL J | director | 150,061 | A-Award | A | 6,325 | 0.00 USD | 0 USD |
| Thursday, May 22nd, 2025 | ACKERMAN THOMAS F | director | 149,896 | A-Award | A | 6,325 | 0.00 USD | 0 USD |
| Thursday, May 22nd, 2025 | Salveson Jon W | director | 129,840 | A-Award | A | 6,325 | 0.00 USD | 0 USD |
| Thursday, May 22nd, 2025 | Hoff Elizabeth A | director | 31,389 | A-Award | A | 6,325 | 0.00 USD | 0 USD |
| Thursday, May 22nd, 2025 | Burbank Jeffrey H | director | 53,796 | A-Award | A | 6,325 | 0.00 USD | 0 USD |
| Thursday, May 22nd, 2025 | Bullock James | director | 68,647 | A-Award | A | 6,325 | 0.00 USD | 0 USD |
| Friday, May 23rd, 2025 | SEMEDO ANTHONY B. | director | 33,059 | S-Sale | D | 2,600 | 28.47 USD | 74,027 USD |
| Wednesday, May 21st, 2025 | Holloway Jean F | officer: SVP, General Counsel | 187,258 | S-Sale | D | 9,926 | 29.00 USD | 287,854 USD |
| Friday, May 9th, 2025 | Stanton Marshall S. | officer: SVP, Clinical & MD Affair | 110,143 | S-Sale | D | 5,737 | 29.13 USD | 167,120 USD |
| Friday, May 9th, 2025 | Stanton Marshall S. | officer: SVP, Clinical & MD Affair | 105,332 | S-Sale | D | 4,811 | 29.13 USD | 140,145 USD |
| Tuesday, March 11th, 2025 | Holloway Jean F | officer: SVP, General Counsel | 215,204 | M-Exempt | A | 19,092 | 21.55 USD | 411,433 USD |
| Tuesday, March 11th, 2025 | Holloway Jean F | officer: SVP, General Counsel | 197,184 | S-Sale | D | 18,020 | 23.61 USD | 425,510 USD |
| Tuesday, March 11th, 2025 | Holloway Jean F | officer: SVP, General Counsel | 0 | M-Exempt | D | 19,092 | 21.55 USD | 411,433 USD |
| Tuesday, March 11th, 2025 | Davis John E | officer: Chief Commercial Officer | 223,878 | M-Exempt | A | 15,910 | 21.55 USD | 342,861 USD |
| Tuesday, March 11th, 2025 | Davis John E | officer: Chief Commercial Officer | 208,778 | S-Sale | D | 15,100 | 23.61 USD | 356,549 USD |
| Tuesday, March 11th, 2025 | Davis John E | officer: Chief Commercial Officer | 0 | M-Exempt | D | 15,910 | 21.55 USD | 342,861 USD |
| Thursday, March 6th, 2025 | Mackin James P | officer: President & CEO | 935,983 | M-Exempt | A | 75,615 | 21.55 USD | 1,629,503 USD |
| Thursday, March 6th, 2025 | Mackin James P | officer: President & CEO | 878,107 | A-Award | A | 115,701 | 0.00 USD | 0 USD |
| Thursday, March 6th, 2025 | Mackin James P | officer: President & CEO | 865,283 | S-Sale | D | 70,700 | 24.76 USD | 1,750,843 USD |
| Thursday, March 6th, 2025 | Mackin James P | officer: President & CEO | 860,368 | S-Sale | D | 17,739 | 24.80 USD | 440,005 USD |
| Thursday, March 6th, 2025 | Mackin James P | officer: President & CEO | 0 | M-Exempt | D | 75,615 | 21.55 USD | 1,629,503 USD |
| Thursday, March 6th, 2025 | Horton Amy | officer: VP, Chief Accounting Officer | 147,699 | A-Award | A | 10,261 | 0.00 USD | 0 USD |
| Thursday, March 6th, 2025 | Horton Amy | officer: VP, Chief Accounting Officer | 146,651 | S-Sale | D | 1,048 | 24.80 USD | 25,995 USD |
| Thursday, March 6th, 2025 | Berry Lance A | officer: Executive VP, CFO | 158,340 | A-Award | A | 48,100 | 0.00 USD | 0 USD |
| Thursday, March 6th, 2025 | Berry Lance A | officer: Executive VP, CFO | 153,431 | S-Sale | D | 4,909 | 24.80 USD | 121,764 USD |
| Thursday, March 6th, 2025 | Davis John E | officer: Chief Commercial Officer | 210,586 | A-Award | A | 25,654 | 0.00 USD | 0 USD |
| Thursday, March 6th, 2025 | Davis John E | officer: Chief Commercial Officer | 207,968 | S-Sale | D | 2,618 | 24.80 USD | 64,939 USD |
| Thursday, March 6th, 2025 | Stanton Marshall S. | officer: SVP, Clinical & MD Affair | 117,483 | A-Award | A | 19,240 | 0.00 USD | 0 USD |
| Thursday, March 6th, 2025 | Stanton Marshall S. | officer: SVP, Clinical & MD Affair | 115,880 | S-Sale | D | 1,603 | 24.80 USD | 39,761 USD |
| Thursday, March 6th, 2025 | Holloway Jean F | officer: SVP, General Counsel | 198,236 | A-Award | A | 25,493 | 0.00 USD | 0 USD |
| Thursday, March 6th, 2025 | Holloway Jean F | officer: SVP, General Counsel | 196,112 | S-Sale | D | 2,124 | 24.80 USD | 52,685 USD |
| Wednesday, March 5th, 2025 | Holloway Jean F | officer: SVP, General Counsel | 172,743 | S-Sale | D | 472 | 25.29 USD | 11,935 USD |
| Wednesday, March 5th, 2025 | SEMEDO ANTHONY B. | director | 35,659 | P-Purchase | A | 1,500 | 25.33 USD | 37,991 USD |
| Wednesday, March 5th, 2025 | SEMEDO ANTHONY B. | director | 600 | P-Purchase | A | 600 | 25.25 USD | 15,150 USD |
| Friday, February 28th, 2025 | Stanton Marshall S. | officer: SVP, Clinical & MD Affair | 98,243 | A-Award | A | 18,398 | 0.00 USD | 0 USD |
| Friday, February 28th, 2025 | Mackin James P | officer: President & CEO | 762,406 | A-Award | A | 98,524 | 0.00 USD | 0 USD |
| Friday, February 28th, 2025 | Horton Amy | officer: VP, Chief Accounting Officer | 137,438 | A-Award | A | 6,297 | 0.00 USD | 0 USD |
| Friday, February 28th, 2025 | Holloway Jean F | officer: SVP, General Counsel | 173,215 | A-Award | A | 23,416 | 0.00 USD | 0 USD |
| Friday, February 28th, 2025 | Davis John E | officer: Chief Commercial Officer | 184,932 | A-Award | A | 24,301 | 0.00 USD | 0 USD |
| Friday, February 28th, 2025 | Berry Lance A | officer: Executive VP, CFO | 110,240 | A-Award | A | 34,435 | 0.00 USD | 0 USD |
| Monday, February 24th, 2025 | Horton Amy | officer: VP, Chief Accounting Officer | 132,758 | S-Sale | D | 1,706 | 27.31 USD | 46,584 USD |
| Monday, February 24th, 2025 | Horton Amy | officer: VP, Chief Accounting Officer | 131,944 | S-Sale | D | 814 | 27.31 USD | 22,227 USD |
| Monday, February 24th, 2025 | Horton Amy | officer: VP, Chief Accounting Officer | 131,626 | S-Sale | D | 318 | 27.31 USD | 8,683 USD |
| Monday, February 24th, 2025 | Horton Amy | officer: VP, Chief Accounting Officer | 131,141 | S-Sale | D | 485 | 27.31 USD | 13,243 USD |
| Monday, February 24th, 2025 | Mackin James P | officer: President & CEO | 689,374 | S-Sale | D | 16,664 | 27.31 USD | 455,027 USD |
| Monday, February 24th, 2025 | Mackin James P | officer: President & CEO | 675,590 | S-Sale | D | 13,784 | 27.31 USD | 376,386 USD |
| Monday, February 24th, 2025 | Mackin James P | officer: President & CEO | 668,778 | S-Sale | D | 6,812 | 27.31 USD | 186,009 USD |
| Monday, February 24th, 2025 | Mackin James P | officer: President & CEO | 663,882 | S-Sale | D | 4,896 | 27.31 USD | 133,690 USD |
| Monday, February 24th, 2025 | Holloway Jean F | officer: SVP, General Counsel | 152,749 | S-Sale | D | 2,385 | 27.31 USD | 65,125 USD |
| Monday, February 24th, 2025 | Holloway Jean F | officer: SVP, General Counsel | 152,259 | S-Sale | D | 490 | 27.31 USD | 13,380 USD |
| Monday, February 24th, 2025 | Holloway Jean F | officer: SVP, General Counsel | 151,449 | S-Sale | D | 810 | 27.31 USD | 22,118 USD |
| Monday, February 24th, 2025 | Holloway Jean F | officer: SVP, General Counsel | 149,799 | S-Sale | D | 1,650 | 27.31 USD | 45,055 USD |
| Monday, February 24th, 2025 | Davis John E | officer: Chief Commercial Officer | 164,242 | S-Sale | D | 2,846 | 27.31 USD | 77,713 USD |
| Monday, February 24th, 2025 | Davis John E | officer: Chief Commercial Officer | 163,651 | S-Sale | D | 591 | 27.31 USD | 16,138 USD |
| Monday, February 24th, 2025 | Davis John E | officer: Chief Commercial Officer | 162,666 | S-Sale | D | 985 | 27.31 USD | 26,896 USD |
| Monday, February 24th, 2025 | Davis John E | officer: Chief Commercial Officer | 160,631 | S-Sale | D | 2,035 | 27.31 USD | 55,568 USD |
| Monday, February 24th, 2025 | Berry Lance A | officer: Executive VP, CFO | 75,805 | S-Sale | D | 3,259 | 27.31 USD | 88,990 USD |
| Monday, February 24th, 2025 | Stanton Marshall S. | officer: SVP, Clinical & MD Affair | 82,233 | S-Sale | D | 2,299 | 27.31 USD | 62,777 USD |
| Monday, February 24th, 2025 | Stanton Marshall S. | officer: SVP, Clinical & MD Affair | 81,763 | S-Sale | D | 470 | 27.31 USD | 12,834 USD |
| Monday, February 24th, 2025 | Stanton Marshall S. | officer: SVP, Clinical & MD Affair | 81,091 | S-Sale | D | 672 | 27.31 USD | 18,350 USD |
| Monday, February 24th, 2025 | Stanton Marshall S. | officer: SVP, Clinical & MD Affair | 79,845 | S-Sale | D | 1,246 | 27.31 USD | 34,023 USD |
| Tuesday, December 31st, 2024 | Davis John E | officer | 0 | 0 | 0.00 USD | 0 USD | ||
| Tuesday, December 31st, 2024 | Stanton Marshall S. | officer | 0 | 0 | 0.00 USD | 0 USD | ||
| Tuesday, December 31st, 2024 | Holloway Jean F | officer | 0 | 0 | 0.00 USD | 0 USD | ||
| Thursday, December 12th, 2024 | Horton Amy | officer: VP, Chief Accounting Officer | 134,464 | G-Gift | D | 1,100 | 0.00 USD | 0 USD |
| Wednesday, December 11th, 2024 | Holloway Jean F | officer: SVP, General Counsel | 157,897 | S-Sale | D | 4,035 | 30.25 USD | 122,059 USD |
| Wednesday, December 11th, 2024 | Holloway Jean F | officer: SVP, General Counsel | 153,862 | S-Sale | D | 4,035 | 30.00 USD | 121,050 USD |
| Friday, December 6th, 2024 | Horton Amy | officer: VP, Chief Accounting Officer | 135,564 | S-Sale | D | 4,425 | 29.05 USD | 128,552 USD |
| Friday, December 6th, 2024 | Horton Amy | officer: VP, Chief Accounting Officer | 135,660 | S-Sale | D | 4,329 | 29.66 USD | 128,398 USD |
| Wednesday, December 4th, 2024 | GREEN ANDREW M | officer: VP Regulatory | 33,503 | S-Sale | D | 7,618 | 30.00 USD | 228,540 USD |
| Tuesday, October 1st, 2024 | Horton Amy | officer: VP, Chief Accounting Officer | 152,419 | M-Exempt | A | 12,430 | 21.55 USD | 267,867 USD |
| Tuesday, October 1st, 2024 | Horton Amy | officer: VP, Chief Accounting Officer | 139,989 | S-Sale | D | 12,430 | 26.18 USD | 325,415 USD |
| Tuesday, October 1st, 2024 | Horton Amy | officer: VP, Chief Accounting Officer | 0 | M-Exempt | D | 12,430 | 21.55 USD | 267,867 USD |
| Monday, August 26th, 2024 | Holloway Jean F | officer: SVP, General Counsel | 161,932 | S-Sale | D | 3,167 | 26.55 USD | 84,096 USD |
| Friday, August 16th, 2024 | Getz Matthew A | officer: VP, Human Resources | 36,678 | S-Sale | D | 6,858 | 25.31 USD | 173,586 USD |
| Friday, August 16th, 2024 | Getz Matthew A | officer: VP, Human Resources | 34,116 | S-Sale | D | 2,562 | 25.31 USD | 64,848 USD |
| Thursday, August 15th, 2024 | Holloway Jean F | officer: SVP, General Counsel | 165,099 | S-Sale | D | 2,383 | 25.76 USD | 61,393 USD |
| Tuesday, August 13th, 2024 | SEMEDO ANTHONY B. | director | 34,159 | S-Sale | D | 9,709 | 24.99 USD | 242,628 USD |
| Thursday, May 30th, 2024 | ACKERMAN THOMAS F | director | 143,571 | A-Award | A | 6,289 | 0.00 USD | 0 USD |
| Thursday, May 30th, 2024 | BEVEVINO DANIEL J | director | 143,736 | A-Award | A | 6,289 | 0.00 USD | 0 USD |
| Thursday, May 30th, 2024 | Salveson Jon W | director | 123,515 | A-Award | A | 6,289 | 0.00 USD | 0 USD |
| Thursday, May 30th, 2024 | Bullock James | director | 62,322 | A-Award | A | 6,289 | 0.00 USD | 0 USD |
| Thursday, May 30th, 2024 | Burbank Jeffrey H | director | 47,471 | A-Award | A | 6,289 | 0.00 USD | 0 USD |
| Thursday, May 30th, 2024 | Borgstrom Marna P | director | 42,763 | A-Award | A | 6,289 | 0.00 USD | 0 USD |
| Thursday, May 30th, 2024 | SEMEDO ANTHONY B. | director | 43,868 | A-Award | A | 6,289 | 0.00 USD | 0 USD |
| Thursday, May 30th, 2024 | Hoff Elizabeth A | director | 25,064 | A-Award | A | 6,289 | 0.00 USD | 0 USD |
| Friday, May 10th, 2024 | Holloway Jean F | officer: SVP, General Counsel | 167,482 | S-Sale | D | 1,250 | 23.42 USD | 29,275 USD |
| Thursday, May 9th, 2024 | Holloway Jean F | officer: SVP, General Counsel | 168,732 | S-Sale | D | 979 | 23.79 USD | 23,286 USD |
| Wednesday, March 20th, 2024 | Stanton Marshall S. | officer: SVP, Clinical & MD Affair | 83,296 | S-Sale | D | 2,183 | 20.39 USD | 44,511 USD |
| Friday, March 15th, 2024 | GREEN ANDREW M | officer: VP Regulatory | 41,121 | S-Sale | D | 1,462 | 20.00 USD | 29,240 USD |
